144 related articles for article (PubMed ID: 19177695)
21. Carcinogenicity.
Maurici D; Aardema M; Corvi R; Kleber M; Krul C; Laurent C; Loprieno N; Pasanen M; Pfuhler S; Phillips B; Prentice D; Sabbioni E; Sanner T; Vanparys P
Altern Lab Anim; 2005 Jul; 33 Suppl 1():177-82. PubMed ID: 16194148
[No Abstract] [Full Text] [Related]
22. Skin irritation and corrosion.
Zuang V; Alonso MA; Botham PA; Eskes C; Fentem J; Liebsch M; van de Sandt JJ
Altern Lab Anim; 2005 Jul; 33 Suppl 1():35-46. PubMed ID: 16194140
[No Abstract] [Full Text] [Related]
23. Eye irritation.
Eskes C; Bessou S; Bruner L; Curren R; Harbell J; Jones P; Kreiling R; Liebsch M; McNamee P; Pape W; Prinsen MK; Seidle T; Vanparys P; Worth A; Zuang V
Altern Lab Anim; 2005 Jul; 33 Suppl 1():47-81. PubMed ID: 16194141
[No Abstract] [Full Text] [Related]
24. [Monitoring cosmetic product safety].
Vigan M
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S55-8. PubMed ID: 17563716
[No Abstract] [Full Text] [Related]
25. Governance, stewardship and cosmetics.
Contact Dermatitis; 2014 May; 70(5):261. PubMed ID: 24731082
[No Abstract] [Full Text] [Related]
26. Skin sensitisation.
Basketter D; Casati S; Gerberick GF; Griem P; Philips B; Worth A
Altern Lab Anim; 2005 Jul; 33 Suppl 1():83-103. PubMed ID: 16194142
[No Abstract] [Full Text] [Related]
27. EEMCO-European group on efficacy measurement and evaluation of cosmetics and other products.
Rodrigues LM
Skin Res Technol; 2018 Aug; 24(3):349-350. PubMed ID: 29995337
[No Abstract] [Full Text] [Related]
28. Reproductive and developmental toxicity.
Bremer S; Cortvrindt R; Daston G; Eletti B; Mantovani A; Maranghi F; Pelkonen O; Ruhdel I; Spielmann H
Altern Lab Anim; 2005 Jul; 33 Suppl 1():183-209. PubMed ID: 16194149
[No Abstract] [Full Text] [Related]
29. Efficacy testing of cosmetic products. A proposal to the European Community by the Danish Environmental Protection Agency, Ministry of Environment and Energy.
Serup J;
Skin Res Technol; 2001 Aug; 7(3):141-51. PubMed ID: 11554699
[TBL] [Abstract][Full Text] [Related]
30. Nanomaterials and regulation of cosmetics.
Bowman DM; van Calster G; Friedrichs S
Nat Nanotechnol; 2010 Feb; 5(2):92. PubMed ID: 20130584
[No Abstract] [Full Text] [Related]
31. [Sanitary control of cosmetics].
Bonini M; Pellino P; Pilla M
Ig Sanita Pubbl; 2005; 61(3):271-84. PubMed ID: 17206194
[TBL] [Abstract][Full Text] [Related]
32. Critical analysis of the safety assessment of cosmetic ingredients performed at the European level.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():58-93. PubMed ID: 18806454
[No Abstract] [Full Text] [Related]
33. Safety assessment of cosmetics in Europe. Foreword.
Elsner P
Curr Probl Dermatol; 2008; 36():XV-XVI. PubMed ID: 19177693
[No Abstract] [Full Text] [Related]
34. UV-induced effects.
Liebsch M; Spielmann H; Pape W; Krul C; Deguercy A; Eskes C
Altern Lab Anim; 2005 Jul; 33 Suppl 1():131-46. PubMed ID: 16194146
[No Abstract] [Full Text] [Related]
35. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part II.
Thyssen JP; Giménez-Arnau E; Lepoittevin JP; Menné T; Boman A; Schnuch A
Contact Dermatitis; 2012 Apr; 66 Suppl 1():25-52. PubMed ID: 22380841
[TBL] [Abstract][Full Text] [Related]
36. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
Rogiers V; Benfenati E; Bernauer U; Bodin L; Carmichael P; Chaudhry Q; Coenraads PJ; Cronin MTD; Dent M; Dusinska M; Ellison C; Ezendam J; Gaffet E; Galli CL; Goebel C; Granum B; Hollnagel HM; Kern PS; Kosemund-Meynen K; Ouédraogo G; Panteri E; Rousselle C; Stepnik M; Vanhaecke T; von Goetz N; Worth A
Toxicology; 2020 Apr; 436():152421. PubMed ID: 32119890
[TBL] [Abstract][Full Text] [Related]
37. [Expected change of direction in Polish law regarding cosmetics].
Karłowski K; Smietanka B; Biernat U; Burzyńska I; Pawłowska K
Rocz Panstw Zakl Hig; 2004; 55(1):21-5. PubMed ID: 15307612
[TBL] [Abstract][Full Text] [Related]
38. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
[TBL] [Abstract][Full Text] [Related]
39. Cosmetic approval.
McCartney M
BMJ; 2012 Sep; 345():e6046. PubMed ID: 22983532
[No Abstract] [Full Text] [Related]
40. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
